Reported 1 day ago
Kenvue Inc. (KVUE), a major player in consumer health products, has seen a significant decline in its stock, dropping 26.6% from its 52-week high and underperforming the Dow Jones Industrial Average by a considerable margin. Over the past year, KVUE's shares have decreased by 19.9%, contrasting with the Dow's 11.7% increase. Despite recent mixed earnings results, analysts maintain a moderately optimistic outlook for Kenvue, with a consensus 'Moderate Buy' rating and a potential price target suggesting a significant upside.
Source: YAHOO